Extavia [interferon beta-1b] Novartis AG"s multiple sclerosis treatment, a copy of Bayer AG"s Betaseron [interferon beta-1b] has been approved by the FDA. The drug allows the company to establish itself within the multiple sclerosis field prior to launching its FTY720 MS pill.